Integrated genomic characterization of endometrial carcinoma DA Levine, ... Nature 497 (7447), 67-73, 2013 | 4809 | 2013 |
Molecular classification of cutaneous malignant melanoma by gene expression profiling M Bittner, P Meltzer, Y Chen, Y Jiang, E Seftor, M Hendrix, M Radmacher, ... Nature 406 (6795), 536-540, 2000 | 2576 | 2000 |
High frequency of BRAF mutations in nevi PM Pollock, UL Harper, KS Hansen, LM Yudt, M Stark, CM Robbins, ... Nature genetics 33 (1), 19-20, 2003 | 2037 | 2003 |
Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy A León-Castillo, SM De Boer, ME Powell, LR Mileshkin, HJ Mackay, ... Journal of Clinical Oncology 38 (29), 3388-3397, 2020 | 493 | 2020 |
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative E Stelloo, T Bosse, RA Nout, HJ MacKay, DN Church, HW Nijman, ... Modern pathology 28 (6), 836-844, 2015 | 423 | 2015 |
Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells JZ Qin, J Ziffra, L Stennett, B Bodner, BK Bonish, V Chaturvedi, F Bennett, ... Cancer research 65 (14), 6282-6293, 2005 | 403 | 2005 |
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes PM Pollock, MG Gartside, LC Dejeza, MA Powell, MA Mallon, H Davies, ... Oncogene 26 (50), 7158-7162, 2007 | 371 | 2007 |
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia PM Pollock, K Cohen-Solal, R Sood, J Namkoong, JJ Martino, A Koganti, ... Nature genetics 34 (1), 108-112, 2003 | 327 | 2003 |
The CDKN2A (p16) Gene and Human Cancer WD Foulkes, TY Flanders, PM Pollock, NK Hayward Molecular medicine 3, 5-20, 1997 | 318 | 1997 |
Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse … H Huynh, VC Ngo, J Fargnoli, M Ayers, KC Soo, HN Koong, CH Thng, ... Clinical Cancer Research 14 (19), 6146-6153, 2008 | 260 | 2008 |
Compilation of somatic mutations of the CDKN2 gene in human cancers: Non‐random distribution of base substitutions PM Pollock, JV Pearson, NK Hayward Genes, Chromosomes and Cancer 15 (2), 77-88, 1996 | 218 | 1996 |
FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features SA Byron, M Gartside, MA Powell, CL Wellens, F Gao, DG Mutch, ... PloS one 7 (2), e30801, 2012 | 212 | 2012 |
Microarray expression profiling in melanoma reveals a BRAF mutation signature S Pavey, P Johansson, L Packer, J Taylor, M Stark, PM Pollock, ... Oncogene 23 (23), 4060-4067, 2004 | 209 | 2004 |
Cloning and characterization of a novel human gene related to vascular endothelial growth factor. S Grimmond, J Lagercrantz, C Drinkwater, G Silins, S Townson, P Pollock, ... Genome Research 6 (2), 124-131, 1996 | 204 | 1996 |
A genome-based strategy uncovers frequent BRAF mutations in melanoma PM Pollock, PS Meltzer Cancer cell 2 (1), 5-7, 2002 | 202 | 2002 |
CDKN2A/p16 Is Inactivated in Most Melanoma Cell Lines M Castellano, PM Pollock, MK Walters, LE Sparrow, LM Down, ... Cancer research 57 (21), 4868-4875, 1997 | 180 | 1997 |
p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas JZ Qin, L Stennett, P Bacon, B Bodner, MJC Hendrix, REB Seftor, ... Molecular cancer therapeutics 3 (8), 895-902, 2004 | 178 | 2004 |
Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation SA Byron, MG Gartside, CL Wellens, MA Mallon, JB Keenan, MA Powell, ... Cancer research 68 (17), 6902-6907, 2008 | 177 | 2008 |
Targeting mutant fibroblast growth factor receptors in cancer H Greulich, PM Pollock Trends in molecular medicine 17 (5), 283-292, 2011 | 173 | 2011 |
Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma MG Gartside, H Chen, OA Ibrahimi, SA Byron, AV Curtis, CL Wellens, ... Molecular Cancer Research 7 (1), 41-54, 2009 | 158 | 2009 |